28179-01-3

Usage

Uses

Used in Pharmaceutical Industry:
1-(7-hydroxyindan-4-yl)ethanone is used as a key intermediate in the synthesis of various pharmaceuticals for its biological activity and potential therapeutic effects.
Used in Organic Synthesis:
1-(7-hydroxyindan-4-yl)ethanone is used as a building block in the production of other organic compounds, contributing to the development of new chemical entities and materials.

Upstream product

• 38997-98-7 acetic acid indan-4-yl ester 
• 13336-31-7 4-methoxylindanone 
• 38998-02-6 1-(7-methoxyindan-4-yl)ethanone 
• 21573-42-2 4-methoxy-2,3-dihydro-1H-indene 
• 40731-98-4 4-hydroxy-2,3-dihydroindan-1-one 
• 1641-41-4 4-indanol 

Downstream Products

• 1312609-70-3 C₁₉H₁₈O₂ 
• 1312609-71-4 C₁₉H₁₆Br₂O₂ 
• 1312608-52-8 C₄₃H₅₄N₄O₁₂ 
• 38998-04-8 7-methoxy-indan-4-ol 

Relevant academic research and scientific papers

COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS AND PHARMACEUTICAL USES THEREOF

The invention provides compounds as hepatitis C virus inhibitors and pharmaceutical uses thereof. Specifically, the invention provides compounds of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.